Skip to main content
Supplement Research and Comparison WebsiteBest Price GuaranteeAbout Us
Supplement Research and Comparison Website

Inhibitory Effect of Vaginal Lactobacillus Supernatants on Cervical Cancer Cells

  • 2017-10-25
  • Probiotics and Antimicrobial Proteins 10(2)
    • Ke-di Wang
    • Dongjiang Xu
    • Baoya Wang
    • Dong-hui Yan
    • Z. Lv
    • J. Su

Abstract

Lactobacilli have been shown to inhibit the proliferation of several types of cancer cells, but the effects of vaginal Lactobacilli on cervical cancer cells have seldom been reported. We incubated Caski cells with supernatants of predominant strains in the vagina and investigated their effects on cell growth and the possible mechanisms. Cell-free supernatants of Lactobacillus crispatus, L. jensenii, and L. gasseri were prepared and purified. Caski cells were treated with various concentrations of Lactobacillus supernatants (LS). The effect of LS on cell growth was investigated using MTT assays. The influence of LS on the cell cycle and expression of human papillomavirus (HPV) E6 and E7 oncogenes was determined by flow cytometry and RT-PCR, respectively. LS-inhibited Caski cell proliferation caused morphological changes in a pH-independent manner. Flow cytometric analysis revealed that cells exposed to LS exhibited a significant increase of cell number in S phase and a strong decrease of cell number in G2/M phase. Expression of HPV E6 and E7 oncogenes, as well as CDK2 and cyclin A was decreased after treatment with LS, while expression of p21 was increased. Supernatants of L. crispatus, L. jensenii, and L. gasseri have inhibitory effects on the viability of cervical cancer cells via regulation of HPV oncogenes and cell cycle-related genes. Lactobacillus, as a promising treatment for cancer, is being assessed for its effect, and these results provide further evidence in this respect.

Keywords: Apoptosis; Caski cell; Cell cycle arrest; Cytotoxic effect; Lactobacillus.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus jensenii LBV 116Reduced Cancer Cell ProliferationBeneficial
Large
Lactobacillus jensenii LJe52Reduced Cervical Cancer Cell ViabilityBeneficial
Moderate
Lactobacillus jensenii VPro 32Increased p21 ExpressionBeneficial
Moderate
Lactobacillus jensenii VPro 32Induced Cell Cycle ArrestBeneficial
Moderate
Lactobacillus jensenii VPro 32Reduced Cancer Cell ProliferationBeneficial
Large
⬆ Back to top
Unsubscribe anytime. See our Privacy Policy.
Pillser
Supplement Research and Comparison Website: evidence-based information about supplements, their benefits, potential risks, and their efficacy.
Join Our Community
Statements on this website have not been reviewed by the U.S. Food and Drug Administration. These products are not meant to diagnose, treat, cure, or prevent any disease. The information here is not a replacement for personal medical advice.